Abstract
The ability to make a large variety of virus-like particles (VLPs) has been successfully achieved in the baculovirus expression vector system (BEVS)/insect cell system. The production and scale-up of these particles, which are mostly sought as vaccine candidates, are currently being addressed. Furthermore, these VLPs are being investigated as delivery agents for use as therapeutics. The use of host insect cells allows mass production of VLPs in a proven scalable system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vicente T, Roldão A, Peixoto C et al (2011) Large-scale production and purification of VLP-based vaccines. J Invertebr Pathol 107:S42–S48
Roldão A, Mellado M, Castilho L et al (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9:1149–1176
Mena J, Kamen A (2011) Insect cell technology as a versatile and robust vaccine manufacturing platform. Expert Rev Vaccines 10:1063–1081
Zheng Y, Greenfield P, Reid S (1999) Optimized production of recombinant bluetongue core-like particles produced by the baculovirus expression system. Biotechnol Bioeng 65:600–604
Maranga L, Cruz P, Aunins J et al (2002) Production of core and virus-like particles with baculovirus infected cells. Adv Biochem Eng Biotechnol 74:183–206
Palomares L, RamÃrez O (2009) Challenges for the production of virus-like particles in insect cells: the case of rotavirus-like particles. Biochem Eng J 45:158–167
Roldão A, Vieira H, Charpilienne A et al (2007) Modeling rotavirus-like particles production in a baculovirus expression vector system: infection kinetics, baculovirus DNA replication, mRNA synthesis and protein production. J Biotechnol 128:875–894
Palomares L, Lopez S, Ramirez O (2002) Strategies for manipulating the relative concentration of recombinant rotavirus structural proteins during simultaneous production by insect cells. Biotechnol Bioeng 78:635–644
Jiang B, Barniak V, Smith R et al (1998) Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis. Biotechnol Bioeng 60:369–374
Park J, Kim H, Hwang H et al (2004) Large-scale production of rotavirus VLP as vaccine candidate using Baculovirus Expression Vector System (BEVS). J Microbiol Biotechnol 14:35–40
Shelly D, Cleave V (2009) Parvovirus B19 VLP vaccine manufacturing. Genet Eng Biotechnol News 29:1–4
Tsao E, Mason M, Cacciuttolo M et al (1996) Production of parvovirus B19 vaccine in insect cells co-infected with double baculoviruses. Biotechnol Bioeng 49:130–138
Maranga L, Brazao T, Carrondo M (2003) Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system. Biotechnol Bioeng 84:245–253
Maranga L, Cunha A, Clemente J et al (2004) Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity. J Biotechnol 107:55–64
Maranga L, Rueda P, Antonis A et al (2002) Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Appl Microbiol Biotechnol 59:45–50
Cruz P, Maranga L, Carrondo M (2002) Integrated process optimization: lessons from retrovirus and virus-like particle production. J Biotechnol 99:199–214
Pillay S, Meyers A (2009) Optimization of chimeric HIV-1 virus-like-particle production in a baculovirus-insect cell expression system. Biotechnol Prog 25:1153–1160
Cruz P, Cunha A, Peixoto C et al (1998) Optimization of the production of virus-like particles in insect cells. Biotechnol Bioeng 60:408–418
Hu Y, Bentley W (2009) Enhancing yield of infectious bursal disease virus structural proteins in baculovirus expression systems: focus on media, protease inhibitors, and dissolved oxygen. Biotechnol Prog 15:1065–1071
Hu Y, Bentley W (2000) A kinetic and statistical-thermodynamic model for baculovirus infection and virus-like particle assembly in suspended insect cells. Chem Eng Sci 55:3991–4008
Haynes J (2009) Influenza virus-like particle vaccines. Expert Rev Vaccines 8:435–445
Krammer F, Schinko T, Palmberger D et al (2010) Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol 45:226–234
Sun Y, Carrion R Jr, Ye L et al (2009) Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology 383:12–21
Sokolenko S, George S, Wagner A et al (2012) Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: benefits and drawbacks. Biotechnol Adv 30:766–781
Haynes J, Dokken L, Wiley J et al (2009) Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 27:530–541
Pushko P, Tumpey T, Bu F et al (2005) Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 23:5751–5759
Ghosh S, Parvez K, Banerjee K et al (2000) Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther 6:5–11
Urabe M, Ding C, Kotin R (2002) Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 13:1935–1943
Meghrous J, Aucoin M, Jacob D et al (2005) Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor. Biotechnol Prog 21:154–160
Aucoin MG, Perrier M, Kamen AA (2006) Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios. Biotechnol Bioeng 95:1081–1092
Aucoin MG, Perrier M, Kamen AA (2007) Improving AAV vector yield in insect cells by modulating the temperature after infection. Biotechnol Bioeng 97:1501–1509
Kamen AA, Bédard C, Tom R et al (1996) On-line monitoring of respiration in recombinant-baculovirus-infected and uninfected insect cell bioreactor cultures. Biotechnol Bioeng 50:36–48
Latham T, Galarza JM (2001) Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Society 75:6154–6165
Peixoto CC, Sousa MFQ, Silva AC et al (2007) Downstream processing of triple layered rotavirus like particles. J Biotechnol 127:452–461
Aucoin MG, Mena JA, Kamen AA (2010) Bioprocessing of baculovirus vectors: a review. Curr Gene Ther 10:174–186
Pushko P, Pearce MB, Ahmad A et al (2011) Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. Vaccine 29:5911–5918
Chahal PS, Aucoin MG, Kamen AA (2007) Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. J Virol Methods 139:61–70
Aucoin MG, Perrier M, Kamen AA (2008) Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnol Adv 26:73–88
Mena JA, Aucoin MG, Montes J et al (2010) Improving adeno-associated vector yield in high density insect cell cultures. J Gene Med 12:157–167
Ishizu K, Watanabe H, Han S et al (2001) Roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein. J Virol 75:61–72
Chun S, Li C, Van Domselaar G et al (2008) Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza a viral hemagglutinins. Vaccine 26:6068–6076
Alain R, Nadon F, Séguin C et al (1987) Rapid virus subunit visualization by direct sedimentation of samples on electron microscope grids. J Virol Methods 16:209–216
Goldsmith CS, Miller SE (2009) Modern uses of electron microscopy for detection of viruses. Clin Microbial Rev 22:552–563
Acknowledgements
The authors would like to thank Johnny Montes, Emma Petiot, Parminder Chahal, Alice Bernier, and Julia Transfiguracion for their helpful advice and input throughout the writing of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Thompson, C.M., Aucoin, M.G., Kamen, A.A. (2016). Production of Virus-Like Particles for Vaccination. In: Murhammer, D. (eds) Baculovirus and Insect Cell Expression Protocols. Methods in Molecular Biology, vol 1350. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3043-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3043-2_14
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3042-5
Online ISBN: 978-1-4939-3043-2
eBook Packages: Springer Protocols